MYO

Myomo, Inc.

$1.27

-9.29%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach.

Source: Yahoo Finance
AI summary

Price & performance

1M-11.2%
3M-11.2%
YTD+28.3%
1Y+38.5%
52-week range—
Beta1.76
Full chart and returns against a benchmark

Q-Score

47/ 100

Quality against peers; 50 is the peer median.

Growth60
Risk41
Performance60
Valuation44
Profitability49
Leverage29
Sentiment69
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$40.9M+25.7%
Net income-$15.6M
Net margin-38.1%-19.1 pts
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeApr 10, 2025
Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

MYOIndustryP/E—29.61P/S1.113.49EV/EBITDA—18.38P/B18.293.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 9next report, after the close
EPS estimate$-0.07
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate